SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

SunTrust Robinson Humphrey Maintains Buy on Catalyst Pharmaceuticals, Lowers Price Target to $10

SunTrust Robinson Humphrey maintains Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Buy and lowers the price target from $11 to $10.

Benzinga · 05/13/2020 13:08

SunTrust Robinson Humphrey maintains Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Buy and lowers the price target from $11 to $10.